| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.02 |